2022
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform
Collaborative T, Tazare J, Walker A, Tomlinson L, Hickman G, Rentsch C, Williamson E, Bhaskaran K, Evans D, Wing K, Mathur R, Wong A, Schultze A, Bacon S, Bates C, Morton C, Curtis H, Nightingale E, McDonald H, Mehrkar A, Inglesby P, Davy S, MacKenna B, Cockburn J, Hulme W, Warren-Gash C, Bhate K, Nitsch D, Powell E, Mulick A, Forbes H, Minassian C, Croker R, Parry J, Hester F, Harper S, Eggo R, Evans S, Smeeth L, Douglas I, Goldacre B. Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform. Wellcome Open Research 2022, 7: 142. PMID: 37362009, PMCID: PMC10285340, DOI: 10.12688/wellcomeopenres.17735.1.Peer-Reviewed Original ResearchDeep vein thrombosisCOVID-19 patientsHigh riskGeneral populationOpenSAFELY platformPulmonary embolismMyocardial infarctionCOVID-19Type 2 diabetes mellitus diagnosisSerious clinical outcomesPrimary care recordsDescriptive cohort studyCOVID-19 populationRisk of outcomesDiabetes mellitus diagnosisAge/sexMajority of outcomesPulmonary complicationsComparator cohortCohort studyIschemic strokeVein thrombosisHeart failureClinical outcomesAdverse outcomes
2013
A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)
Guest JL, Weintrob AC, Rimland D, Rentsch C, Bradley WP, Agan BK, Marconi VC, Group I. A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS). PLOS ONE 2013, 8: e62273. PMID: 23658717, PMCID: PMC3641058, DOI: 10.1371/journal.pone.0062273.Peer-Reviewed Original ResearchConceptsNatural history studiesUS Military HIV Natural History StudyVeterans AffairsCohort studyClinical outcomesHIV treatmentComprehensive HIV treatmentHealthcare systemHistory studiesClinic retentionHAART initiationHAART outcomesCause mortalityAIDS eventsHIV diagnosisSurvival disparitiesStudy cohortDemographic variablesMedication adherenceCrude analysisSurvival ratePatientsSubstance abuseHIVCare